FDA oncologic gene and cellular therapies
FDA Division of Oncologic Drug Products Medical Officer Steven Hirschfeld, MD/PhD, will become Oncology Group Leader in the Office of Cellular, Gene & Tissue Therapies in the Center for Biologics Evaluation & Research. Hirschfeld assumes the position starting Nov. 3...
You may also be interested in...
The Office of Cellular, Gene & Tissue Therapies' new oncology group will work to ensure coordination in approaches to oncology products throughout FDA
Roche’s Q1 update highlighted some key coming drug catalysts and early stage clinical efforts, including those for a potential COVID pill and for targeted cancer vaccines.
India has approved a $46m project by giving the green light to 16 drug production applications under the Production Linked Incentive scheme. The government has ordered the setting up and commercial production of the 16 projects to commence immediately.